Programme
KNOW MORE ON INFLAMMATION
21st February 2025 – 08.30 – 09.30
SESSION II: INFLAMMATION IN BRONCHIECTASIS
Chairs: Stefano Aliberti (Italy) – Veronique Witko–Sarsat (France)
Impacts of inflammation on the epithelium Amelia Shoemark (UK)
Eosinophilic inflammation Michal Shteinberg (Israel) Â
Autoimmunity in bronchiectasis Clémence Martin (France)
INSIGHTS INTO NEW THERAPIES
21st February 2025 – 09.30 – 10.30
SESSION III: TREATMENT TARGETS IN BRONCHIECTASIS
Bronchiectasis – new treatments James D. Chalmers (UK)
NTM – new treatments Charles L. Daley (USA)
EBROW BATTLE 1
21st February 2025 – 12.30 – 13.00
BRONCHIECTASIS BATTLE: PSEUDOMONAS ERADICATION
Chair: Francesco Blasi (Italy)
Discussants: Antony de Soyza (UK), Frederic Schlemmer (France)
EBROW BATTLE 2
21st February 2025 – 15.00 – 15.30
BRONCHIECTASIS BATTLE: ICS IN BRONCHIECTASIS
Chair: Adam Hill (UK)
Discussants: Marc Miravitlles (Spain), Nicolas Roche (France)
EBROW BATTLE 3
22nd February 2025 – 12.00 – 12.45
BRONCHIECTASIS BATTLE: SHOULD WE MANAGE PATIENTS WITH CF ON CFTR MODULATORS AS NON CF BRONCHIECTASIS?
Chairs: Isabelle Fajac (France), Felix Ringshausen (Germany)
Discussants: Pros: Andrea Gramegna (Italy), Cons: Pierre-Régis Burgel (France)
The Programme Highlights web tool has been made possible, thanks to the independent unrestricted support grant from:
| Â | Monday, 5th February 2024 | Tuesday, 6th February 2024 | Wednesday, 7th February 2024 |
| Morning | Â | – Lung Microbiome – Tuberculosis – RSV – Respiratory Syncytial Virus | – Pleural infection – Bronchiectasis – Bacterial Infection – Viral Infection |
| Afternoon | – CAP – Community Acquired Pneumonia – Pneumonia – Influenza – Covid-19 | – Bacterial Infection – Exacerbation – NTM (Non Tuberculosis Mycobacterial | Â |
